🇺🇸

Index Intelligence

· daily

S&P 500 Healthcare Sector SEC Filings — March 18, 2026

Across the 33 filings in the USA S&P 500 Healthcare stream (with broader cross-sector context), healthcare firms show mixed performance: service providers like Pacific Health Care Organization achieved +11% YoY revenue and +57% net income growth, while device/biotech players like Lifeward (-14% FY revenue) and Cingulate (+35% net loss YoY) faced headwinds amid Nasdaq compliance risks (e.g., CalciMedica) and funding needs (Artelo Biosciences bridge notes). Financial peers (non-core but contextual) displayed resilient net income growth averaging +55% YoY (Sound Financial +54%, AmeriServ +56%) with NIM expansions (+45bps to +34bps), contrasting healthcare's revenue declines in 3/7 key firms averaging -14%. Proxy season ramps up with healthcare giants like Boston Scientific filing DEFA14A/DEF14A, signaling governance focus; capital allocation leans conservative (e.g., First Financial $0.56 dividend). Forward catalysts cluster in H1 2026, including Cingulate's PDUFA May 31 and CalciMedica compliance deadlines Sep 2026. Portfolio implication: favor healthcare services over devices/biotech amid volatility, monitor small-cap delisting risks.

18 high priority 15 medium 33 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — March 17, 2026

Across 50 filings in the USA S&P 500 Consumer Staples intelligence stream (with broader equity exposure), mixed financial results dominate, with 12/50 showing YoY revenue growth averaging +25% driven by acquisitions (e.g., Intelligent Protection +2050%, ClearPoint +18%), offset by declines in 8/50 averaging -20% (e.g., Telesat -26.8%, Skkynet -34%). Margin compression is evident in 7/15 detailed financials (avg -200 bps, e.g., lululemon -260 bps), while gross margins held steady in others like ClearPoint at 61%. Capital allocation trends favor buybacks (Coca-Cola Europacific 356k shares) and redemptions (Wells Fargo Series BB), with M&A active (Brookfield $2B acquisitions, ClearPoint IRRAS). Forward-looking catalysts include ClearPoint's 2026 revenue guide $52-56M (+42% midpoint), Monte Rosa cash to 2029, and SPAC extensions (Pelican, Israel Acquisitions to Apr 2026). Board enhancements signal conviction (lululemon Chip Bergh, Peloton Sarah Robb O’Hagan), but biotech/consumer names like lululemon show regional divergences (China +29% vs Americas -1%). Portfolio implication: Favor acquisition-driven growers amid margin pressures; monitor SPAC redemptions and Q1 guidance.

33 high priority 17 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — March 17, 2026

Across 50 SEC filings from the USA S&P 500 Industrials stream (March 17, 2026), dominant themes include accelerating bank M&A with regulatory approvals for UBFO/CWBC and Mechanics/HomeStreet mergers driving asset/deposit growth (e.g., +36% YoY) but offset by NIM compression (Bank7 -17bps, Mechanics +12bps mixed) and rising provisions; explosive revenue surges post-acquisitions (INTELLIGENT PROTECTION +2050% YoY to $23.6M, Phoenix Energy +144% to $687M); SPAC distress with extensions (AlphaTime trust down to $4.8M from heavy redemptions) and LOIs for financing. Period-over-period trends reveal mixed revenue growth (8/20 financials showed +10-800% YoY boosts from deals, 6 declined >10%), margin pressures (Urban One EBITDA -38%, Bank7 NIM -17bps), but positive guidance in industrials (Andersen +14-15% rev FY26, Phoenix 15.5-16.8M Boe). Capital allocation leans shareholder-friendly (dividends at First Guaranty 131st consecutive, buybacks at New Peoples 500k shares, IZEA $10M program); 15+ proxy filings signal Q2 governance catalysts. Implications: Favor M&A beneficiaries and high-growth acquirers amid sector consolidation, monitor SPAC deadlines and delistings like Urgent.ly.

30 high priority 20 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — March 17, 2026

The three filings in the USA S&P 500 Energy intelligence stream highlight divergent paths: two positive 425 filings on AParadise Acquisition Corp.'s $1.3B SPAC merger with Enhanced Games (sports innovation with PEDs under medical supervision), signaling bullish investor interest via Accelerate Arbitrage Fund's long position, contrasted by Idaho Copper Corp.'s mixed 10-K showing pre-revenue status with zero revenue FY2026 vs FY2025, 44% YoY operating expense decline to $2.6M, and 40% net loss improvement to $3.1M, but critically low cash at $24K (down from $101K) and widening stockholders' deficit to $6.5M. Period-over-period trends reveal cost discipline at Idaho (professional fees -39%, stock-based comp -51%, rent -89%) amid liquidity erosion, with no revenue growth across filings underscoring pre-commercial stages. Key developments include Enhanced Games' May 2026 Las Vegas debut and Abu Dhabi training, positioning AParadise for catalysts, while Idaho's stable $3.13M bond liabilities and $2.31M accrued interest flag balance sheet risks. Portfolio-level patterns show innovation-driven SPAC optimism vs resource extraction distress, with positive sentiment dominating (2/3 filings) but materiality highest for Idaho (9/10). Market implications favor event-driven plays in AParadise amid energy transition themes (e.g., athlete health tech parallels), while urging caution on Idaho's near-term survival.

3 high priority 3 total filings
· daily

S&P 500 Financials Sector SEC Filings — March 17, 2026

Across 50 diverse SEC filings (despite Financials stream focus, including banks, asset managers, SPACs, industrials, biotech), overarching themes include robust M&A/SPAC activity (e.g., Victory Capital's improved Janus Henderson bid, bank mergers like UBFO/CWBC), mixed revenue growth with outliers like Energy Vault's 340% YoY surge and Mechanics Bancorp's 817% net income jump post-merger, but persistent margin pressures and widening losses in media/retail (Urban One -16.5% YoY rev). Period-over-period trends show 12/25 reporting companies with revenue growth averaging +45% YoY where positive, but 8/20 with margin compression (avg -150bps, e.g., Xerox -440bps gross), and Adjusted EBITDA improvements in 7 cases (e.g., Citi Trends +$26M FY YoY). Financials subset (Mechanics, Bank7, Victory, T Rowe, TWO Harbors) highlights asset/deposit growth (+36% YoY) and accretive deals, offset by NIM declines (-12bps to -117bps). Critical developments: regulatory approvals advancing bank mergers (Q2 2026 closes), SPAC extensions/mergers, and positive guidance (Energy Vault 30% 2026 rev growth). Portfolio implications: overweight growing financial consolidators, monitor SPAC redemptions/deadlines for dilution risks, favor revenue accelerators amid macro uncertainty.

34 high priority 16 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — March 17, 2026

Across the 8 filings in the USA S&P 500 Technology stream, dominant themes include advancing SPAC de-SPAC mergers (AParadise with Enhanced Games, dMY Squared with Horizon Quantum) and bank-tech adjacent mergers (Community West Bancshares), alongside restructuring at PSQ Holdings with strong revenue growth but cash burn, proxy preparations at Altimmune, and shelf registration post-divestitures at Planet Green. Period-over-period trends highlight PSQ's revenue surge (+81% FY YoY, +109% Q4 YoY) and loss improvements (-37% FY net loss YoY), contrasted by sharp cash declines (-59% YoY to $14.6M) and equity drops (-50% to $13.4M), with no other filings showing financial metrics but positive merger progress. Critical developments like regulatory approvals, shareholder votes, and 2026 event timelines (e.g., Enhanced Games May 2026) signal near-term catalysts amid mixed sentiment (4 positive, 3 mixed, 1 neutral). Portfolio-level patterns reveal M&A momentum in 4/8 filings, operational restructurings for cost savings (PSQ staff cuts >40%, $8M annualized savings), and divestitures of underperformers (Planet Green), implying sector focus on consolidation and efficiency despite cash pressures. Market implications favor event-driven trades around Q1-Q2 2026 catalysts, with relative outperformance in revenue growers like PSQ vs. stagnant peers.

4 high priority 4 medium 8 total filings
· daily

Nasdaq 100 Stocks SEC Filings — March 17, 2026

Across the 8 NASDAQ-100 related filings dated March 17, 2026, dominant themes include M&A momentum with SPAC and bank mergers advancing toward Q2 2026 closures, explosive post-acquisition revenue growth at IPM (2050% YoY to $23.6M FY2025), and early product wins like AITX's order, contrasted by mixed profitability signals and routine governance actions. Period-over-period trends highlight IPM as a hypergrowth outlier with Q4 revenue +2092% YoY to $6.1M but -1.7% QoQ decline, net losses improving 77% YoY to $2.0M annually, positive Q4 Adjusted EBITDA of $5K, and operating cash flow turning positive; no comparable metrics in other filings limit broader aggregation but underscore IPM's relative outperformance. Critical developments like regulatory approvals for CWBC-USB merger and AParadise-Enhanced Games $1.3B combination signal near-term catalysts, while IPM's $400K buyback (76% executed) and zero long-term debt reflect prudent capital allocation. Portfolio-level patterns show 4/8 filings positive on growth/M&A, 2 mixed on IPM's losses/litigation, and 2 neutral on governance/shelf, implying bullish M&A tailwinds but watch for dilution/integration risks. Overall, actionable intelligence favors positioning ahead of March-April shareholder votes and May 2026 Enhanced Games debut, with IPM as a high-beta turnaround play.

4 high priority 4 medium 8 total filings
· daily

Dow Jones 30 Stocks SEC Filings — March 17, 2026

Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (March 17, 2026), dominant themes include robust M&A and SPAC activity in finance (e.g., bank mergers like United Security/Community West and Two Harbors/UWM), explosive revenue growth in energy storage (Energy Vault +340% YoY) and select tech/biotech, offset by margin compression and net loss widening in 12/50 companies averaging -25% YoY net income growth where reported. Period-over-period trends show 18 companies with revenue growth >20% YoY (avg +85%), but 14 with margin contraction (avg -250 bps) and 10 with cash burn acceleration (avg +35% YoY); banks exhibit deposit growth (+36% YoY Mechanics) amid NIM stability/declines. Forward-looking catalysts cluster in Q2 2026 (e.g., merger closings, Phase 3 trials), with capital allocation favoring debt refinancings (Indivior $500M notes) and buybacks/dividends ($1.69B CF Industries returns). Mixed sentiment prevails (28/50), signaling portfolio-level caution on profitability amid growth; outliers like BW Industrial IPO ($17.1M proceeds) and Vireo M&A highlight alpha in industrials/cannabis. Implications: Rotate into high-backlog growth (Energy Vault $1.3B) and monitor bank consolidations for synergies, while hedging media/tech declines (Urban One -16% rev, Baidu -3%).

30 high priority 20 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 17, 2026

Across 50 filings in the S&P 500 Consumer Discretionary stream (with cross-sector context from retail, hotels, airlines, and adjacent), key themes include robust revenue growth in 8/14 reporting companies (avg +45% YoY, led by Dragonfly +15.8%, Fold +34%, Marwynn +122%) offset by widespread margin compression (avg -200bps) and widening losses (e.g., Fold op loss to $27.7M, SafeSpace -41% YoY), signaling cost pressures amid RV/auto softness and ops disruptions. Capital allocation remains shareholder-friendly with new buybacks ($250M First Industrial, Kforce 10b5-1 plan, CF $1.37B repurchases), steady dividends (Waterstone quarterly, First Guaranty 131st consecutive), and M&A activity ($800M+ Infinity upstream, Fulgent $56.9M assets, Farmer Bros merger). Proxy season ramps up with 15+ AGMs in April-May 2026, highlighting board refreshers and comp votes. Forward guidance mixed: Dragonfly targets EBITDA positivity at $70M run-rate, Frontier Q1 loss $0.32-0.44 amid fuel spikes. Portfolio-level: 6/10 high-materiality filings show mixed sentiment, with hotels/entertainment stable but airlines volatile; actionable now on buybacks amid undervalued growth names.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — March 17, 2026

Across 41 diverse SEC filings labeled under USA S&P 500 Healthcare (though spanning retail, biosciences, energy, finance, and more), overarching themes include modest revenue growth averaging ~12% YoY in 8/41 reporting companies (e.g., Lifeway +14%, PURE Bioscience +22%, Zeo +33%), offset by persistent net losses in biosciences and cash burn concerns; margin expansions noted in standouts like Citi Trends (+210bps FY to 39.6%) and Lifeway (+140bps to 27.4%). Healthcare-adjacent biosciences (7 filings) show revenue up avg 15% YoY but mixed sentiment with narrowing losses (PURE -16%, Cibus -53%) amid clinical catalysts and M&A (Rallybio merger). Capital allocation leans toward buybacks (News Corp $1B program, New Peoples 500k shares) and dividends (Waterstone quarterly), while energy names like New Fortress face severe restructuring (debt cut to $527.5M, shareholder dilution to 35%). Critical developments: bioscience efficiency gains and product launches (Cibus rice traits 2027-28), SPAC mergers for growth (Abra $10B AUM target 2027), but restatements/restatements signal control weaknesses. Portfolio implications: selective opportunities in high-growth biosciences/turaround retail, caution on cash-strapped microcaps and leveraged restructurings.

19 high priority 22 medium 41 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — March 16, 2026

Across 50 filings in the USA S&P 500 Consumer Staples intelligence stream (with broader cross-sector context), dominant themes include steady capital returns via dividends (Benchmark $0.17/shr, Pebblebrook $0.01 common + prefs, Coca-Cola resilient outlook), frequent leadership transitions signaling strategic shifts (KORU CEO retirement 6/30/26, Helmerich CFO 6/30/26, Coca-Cola CEO to Henrique Braun), and mixed financials with revenue acceleration in 8/18 reporting companies averaging +32% YoY (Telos +52%, Gilat +48%, OPAL +16%) offset by margin compression in 7/12 cases averaging -380bps (Gilat -700bps, Dell products -210bps). Period-over-period trends reveal improving cash flows in turnarounds (Telos op CF +$56.1M to $30.2M, Comtech H1 +$34.9M to $12.9M) but widening losses in 6/15 small caps (KEEMO -62% worse, FutureFuel rev -61%). Forward-looking catalysts cluster in Q2-Q3 2026 (DuPont aramids sale 4/1, Black Diamond GBM trial Q2, Rafael topline Q3), with OPAL's 2026 EBITDA guidance $95-110M as a growth beacon. Portfolio implications favor selective longs in high-growth outliers like OPAL/Telos amid sector volatility, with watch for M&A closes and trial readouts driving alpha.

28 high priority 22 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — March 16, 2026

Across 50 filings in the USA S&P 500 Industrials stream, key themes include robust revenue acceleration in power/infrastructure plays like Forgent Power Solutions (+69% YoY to $296M Q2, bookings +268%) and WaterBridge (+66% YoY to $525.6M FY25), offset by volume pressures in defense (SAIC -5% YoY Q4) and machinery (Comtech -16% YoY Q2 sales). Aggregate period trends: 8/15 revenue-reporting firms showed +20%+ YoY growth (avg +55%), but 6/10 reported net losses or widened due to one-offs, impairments, and debt costs; margins resilient in 4 cases (Comtech +720bps, SAIC +20bps FY). Capital allocation bullish with $422M SAIC buybacks, Amphastar +$50M program, multiple dividend hikes/initiations (ServisFirst $0.38, WaterBridge $0.05). M&A active: Public Storage-NSA merger (multiple filings), Addentax Keemo acquisition. Banks exhibit NI surges (+45% PCB, +49% Orange County) but rising NPAs/NPLs (+69% PCB nonaccruals, +76% Orange NPLs). Forward-looking signals mixed: Forgent +73% FY26 guide vs SAIC -4-2% organic; catalysts cluster Mar-Apr AGMs/earnings and Q2 2026 BLAs. Actionable: overweight infra growth, monitor credit deterioration.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — March 16, 2026

Across the 8 S&P 500 Energy stream filings (with some industrial/biotech outliers), key themes include robust revenue growth in 5/8 companies (e.g., Ampco-Pittsburgh +4% YoY FY sales to $434.2M, Stoke +404% YoY to $184M) offset by one-time losses and margin pressures, exemplified by Ampco's Q4 Adjusted EBITDA -47% YoY to $3.2M and FY operating loss of $(54.5M). Energy pure-plays shine: Marathon Petroleum (MPC) reported $4.0B 2025 net income, $12.0B adjusted EBITDA, 94% refining utilization, and $4.5B shareholder returns including 10% dividend hike to $1.00/share, while Dorchester Minerals secured $15.5M litigation settlement boosting April 2026 distributions. Capital allocation leans shareholder-friendly in energy (MPC $4.4B buyback authorization remaining), with forward-looking uplift from Ampco's UK facility exit ($7-8M annual EBITDA). Proxies signal routine governance (MPC DEFA14A/DEF14A, Peapack), but mixed sentiment prevails in 3/8 filings due to charges/backlog declines. Portfolio implications: Favor MPC/Dorchester for near-term yields; monitor Ampco/Stoke turnarounds amid Q4 weakness. Catalyst-rich: Earnings calls and AGMs in March-April 2026.

5 high priority 3 medium 8 total filings
· daily

S&P 500 Financials Sector SEC Filings — March 16, 2026

Across 50 filings from S&P 500 Financials and related streams, overarching themes include mixed financial performance with revenue declines averaging -7% YoY in 14/25 reporting companies (e.g., Townsquare -5.2%, iQIYI -6.6%, LivePerson -22%) offset by aggressive cost reductions boosting operating income (e.g., Townsquare +103.8%) and EBITDA (WaterBridge +68% to $254M); notable M&A and capital markets activity like Kennedy-Wilson merger amendments requiring 2/3 vote excl. insiders, Armada Hoffler $562M asset sale, and MSC Income $150M notes. Fintech standouts like Figure Technology (+48.7% rev to $507M, +574% NI) and Blend Labs (+7% rev, op cash flow positive $14.4M) contrast with bank/insurer stability (PCB Bancorp +45% NI, AIG director exit neutral). Capital allocation favors buybacks (Amphastar +$50M) and dividends (Townsquare $0.20 qtrly, PCB +11%), while SPACs extend deadlines amid redemptions (Trailblazer to June 2026). Forward guidance mixed but growth-oriented (Townsquare FY2026 $420-440M rev, WaterBridge +7-9% EBITDA), signaling portfolio-level resilience amid sector rotation opportunities. Implications: Favor fintech/bank growth outliers, monitor merger votes and Q1 catalysts for alpha.

32 high priority 18 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — March 16, 2026

Across 14 SEC filings in the USA S&P 500 Technology stream, revenue declines dominate with 4 key reporters averaging -10.7% YoY (Townsquare -5.2%, Comtech Q2 -15.6%/H1 -10.2%), driven by broadcast/advertising weakness and product eliminations, but countered by margin expansions via cost cuts (Comtech gross margin +720bps to 33.9%, Adjusted EBITDA +214% to $9.1M; Townsquare op income +103.8%). Capital allocation trends bullish in software giants: Intuit accelerated buybacks +40% YoY to $1.8B H1 with $3.5B remaining after terminating 10b5-1 sales plans; Salesforce $25B ASR signals conviction. Digital shifts resilient (Townsquare digital +0.9% to 55% of rev), turnarounds evident (Nuvera NI +107.4% to $0.3M from $4.4M loss), but debt pressures persist (Townsquare leverage 5.19x, interest +32.3%). Mixed sentiment in 5/14 filings reflects operational resilience amid macro headwinds; backlog strength (Comtech $732M, +120.9% bookings) flags recovery potential. Guidance cautious (Townsquare FY26 rev $420-440M flat YoY), with catalysts like AParadise De-SPAC and May events. Portfolio implication: overweight buyback leaders (Intuit, Salesforce), monitor small-cap debt for downside.

8 high priority 6 medium 14 total filings
· daily

Nasdaq 100 Stocks SEC Filings — March 16, 2026

Across the 13 NASDAQ-100 related filings from March 16, 2026, key themes include margin expansion and profitability improvements despite revenue softness in select companies like Comtech (Q2 sales -15.6% YoY but gross margin +720 bps to 33.9%, Adjusted EBITDA +214% to $9.1M), contrasting with positive capital allocation signals such as Intuit's termination of 10b5-1 sales plans and acceleration of $3.5B share repurchases (H1 repurchases +40% YoY to $1.8B). Amazon's €14.5B Euro notes issuance at low coupons (2.8%-4.85%) signals strong access to cheap debt markets, while SPAC/IPO activity (Metals Acquisition $200M IPO, Madison Air S-1/A) highlights M&A momentum. Governance enhancements (CoStar's new AI-experienced director) and operational outperformance (AParadise's AOV +18%, subscription +25%) point to AI/data tailwinds, but debt pressures persist (Nuvera interest expense up, Comtech non-current debt +$7.9M to $103.5M). Portfolio-level trends show 3/5 detailed financial reporters with YoY profitability gains (e.g., Comtech H1 gross profit +51.3%, Nuvera net income +107.4% from loss), mixed revenue (2 declines averaging -13%), and bullish capital returns. Critical implications: Favor margin turnarounds and buyback accelerators amid soft revenue; monitor De-SPACs and reporting changes for catalysts.

8 high priority 5 medium 13 total filings
· daily

Dow Jones 30 Stocks SEC Filings — March 16, 2026

Across 50 SEC filings from Dow Jones 30-focused stream (Mar 16, 2026), key themes include resilient banking sector growth with net income up 45-49% YoY in PCB Bancorp/Orange County Bancorp amid NIM expansion, contrasted by revenue declines averaging -15% YoY in tech/defense firms like SAIC (-3% FY26), LivePerson (-22%), and Comtech (-15.6% Q2 FY26), though margins improved (e.g., Comtech gross margin +720bps to 33.9%). M&A activity surged with 6 deals (Interactive Strength/Ergatta $3.5M+$5-9.5M stock, Allison/Dana $2.73B, Zevra SDX sale $50M), leadership transitions in 10+ firms (Fortune Brands interim CEO, Baxter interim CFO), and capital returns via dividends/buybacks (SAIC $422M FY26 repurchases, ServisFirst $0.38/share). Mixed sentiment dominates (18/50), with forward guidance cautious (SAIC FY27 rev -4-2% organic) but clinical catalysts (Perspective VMT-α-NET mid-2026 data) and bank efficiency gains (PCB ROA 1.15% +). Portfolio implications: overweight banks for NIM tailwinds, monitor tech margin recovery vs rev weakness, position for M&A catalysts.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — March 16, 2026

Across the 50 filings in the USA S&P 500 Consumer Discretionary intelligence stream (despite diverse inclusions like infra/energy/crypto), mixed sentiment dominates with 18/50 showing mixed signals, driven by robust revenue growth in select names (e.g., Forgent Power +69% YoY Q2 rev to $296M, Figure Tech +48.7% FY25 to $507M) offset by declines (SFL Corp -19% rev to $733M, FutureFuel -61% to $95.7M). Period-over-period trends reveal YoY revenue acceleration in 15/50 companies averaging +40% where positive, but margin compression in 12/50 (avg -100bps) and net losses widening in 10/50 due to impairments/expenses. Capital allocation shines with dividends declared/initiated in 5 names (ServisFirst $0.38/shr, WaterBridge $0.05/shr quarterly) and buybacks noted (Truist $10B program, Marathon $4.5B returned). M&A momentum includes NSA/Public Storage merger (3 filings), Armada Hoffler $562M asset sale, and KEEMO control stake acquisition. Forward-looking guidance is bullish in infra/power (Forgent FY26 rev $1.275-1.325B +73%), with April 2026 AGMs (Ferguson, Truist, Marathon) as key catalysts. Crypto ETF index changes (Grayscale BTC/ETH, 5 filings) are neutral operational tweaks effective Apr 1. Portfolio implication: favor growth infra/consumer plays amid capex cycles, monitor M&A for consolidation.

28 high priority 22 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — March 16, 2026

In the USA S&P 500 Healthcare stream, biotech and medtech firms dominate with mixed but stabilizing financials: revenues grew in devices (Smith & Nephew +6.1% YoY) while core sales declined in nutritionals (USANA -8.3% YoY), and biotechs narrowed losses (Rallybio -84% net loss YoY, HeartSciences -4% 9mo) amid pipeline catalysts. Cash positions strengthened significantly (Alto +5% to $177M funding into 2028, HeartSciences +209% to $3.4M), supported by $120M Alto raise and operational efficiencies (Rallybio opex -44% YoY). Broader filings reveal robust capital returns (SAIC $422M FY26 buybacks, Truist $10B new program, $5.2B returned 2025) and proxy season peaks with 10+ April 2026 meetings. Forward-looking optimism in healthcare via Alto's 1Q26/1H26 data/trials, Moderna's 8 oncology programs, Smith & Nephew's 6-7% CAGR RISE plan to 2028. Portfolio trends: 5/8 key HC firms improved cash/equity YoY, but margins compressed avg -150bps in 3/8 (USANA -370bps op); non-HC financials showed net income growth avg +25% YoY (SMARTFinancial +39%). Critical implications: Biotech catalysts cluster 1H26, signaling alpha in small/mid caps; monitor dilution from raises and weak bookings (SAIC Q4 btb 0.3x).

30 high priority 20 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — March 13, 2026

Across 50 recent SEC filings from the USA S&P 500 Consumer Staples intelligence stream (with broader equity coverage), overarching themes include sustained capital returns via dividends and buybacks amid mixed FY2025/Q4 results, neutral-to-positive insider activity focused on planned diversification rather than opportunistic selling, and cautious forward-looking guidance with strategic reviews in non-core assets. Period-over-period trends reveal revenue growth in 7/15 detailed reporters (avg +12% YoY, e.g., monday.com +27%, CCEP +FX-neutral), but margin compression in 6/15 (avg -100bps, e.g., Velocity NIM -11bps, Aspen gross margin -2300bps), offset by efficiency gains (e.g., Fidelity D&D efficiency ratio -590bps to 60.3%). Critical developments feature CCEP's strong €20.9B revenue and €1B buyback completion signaling staples resilience, Walmart executives' 10b5-1 plans for routine sells up to $15M through 2029 (neutral conviction), and Petco/El Pollo Loco's modest sales growth (+3.6%/-2.5%) with profitability improvements. Portfolio-level patterns show 9/50 filings with dividends/buybacks (e.g., GIII $0.10, Ford 31.7M shares), indicating robust shareholder focus despite sector headwinds like flat same-store sales (El Pollo 0.1%). M&A/strategic processes (e.g., Barnwell oil/gas review, Monroe approvals) add alpha potential, while layoffs (Modular 29% workforce) flag cost pressures. Implications favor defensive staples plays with yields, monitoring catalysts like March 18 hearings and Q1 earnings.

26 high priority 24 medium 50 total filings